期刊文献+

微小型生物反应器及其在生物医药领域的应用展望 被引量:6

Application of micro-and mini-bioreactors in biomedicine development and production
原文传递
导出
摘要 微小型生物反应器体积微小但在线分析检测和过程控制功能媲美台式装备。其核心支撑技术包括一次性材料及微加工技术、非接触式光学传感器、自动化以及实验设计(DOE)、数据分析软件与过程控制的整合。由于体积微小、湍流程度和单位能耗较低,微小型反应器内的混合、传质、剪切特性与工业规模设备有一定的区别。现阶段微小型生物反应器主要用于菌株和细胞系筛选和工艺优化,在实现高通量工艺的同时确保了数据的丰度,对缩短研发周期和加速产品上市,尤其是在应对突发性传染性疾病方面有着重要的意义。未来,精准医疗概念的落实也依赖功能柔性化的微小型生物反应器系统。 Micro-and mini-bioreactors are characterized by their miniature working volume and comprehensive monitoring of process data,e.g.,biomass,pH,dissolved oxygen,and fluorescence that are on par with conventional bench-top systems.The technical advancements of micro-and mini-bioreactors are supported by single-use material and micro-manufacturing,non-invasive optical sensors,automation such as industrial robotics and the integration of design of experiment software with data acquisition and process control.Owing to the miniature scales,micro-bioreactors typically feature lower turbulence intensity and energy dissipation rate,resulting in different mass transfer,mixing and shear conditions as compared to industrial scale equipment.Mini-bioreactors,nevertheless,are closer to large vessels.Micro-and mini-bioreactors are used mostly in screening and process development nowadays,owing to their combined high throughput and richness of data.They are also the hardware that will enable“precision medicine”in the near future.
作者 李雪良 钱钧弢 刘金 房峻 陈坚 Xueliang Li;Juntao Qian;Jin Liu;Jun Fang;Jian Chen(School of Biotechnology,Jiangnan University,Wuxi 214122,Jiangsu,China;T&J Bioengineering(Shanghai),Ltd.,Shanghai 201611,China)
出处 《生物工程学报》 CAS CSCD 北大核心 2020年第11期2241-2249,共9页 Chinese Journal of Biotechnology
基金 国家自然科学基金(No.31830068) 中央高校基本科研业务费专项资金(No.JUSRP12011)资助。
关键词 微型生物反应器 平行生物反应器 高通量技术 生物医药 micro-bioreactor parallel-bioreactor high throughput technology biomedicine
  • 相关文献

参考文献3

二级参考文献26

  • 1Schappcr D, Alam M N H Z, Szit,a N, et al. Application of microbioreactors in fermentation process development: a review. Anal Bioanal Chem, 2009, 395 (3): 679-695.
  • 2L6ffelholz C, Husemann U, Greller G, et at. Bioengineenng parameters for single - use bioreactors: overview and evaluation of suitable methods. Chew. lag T:ch, 2013, 85 (2): 40-56.
  • 3Kostov Y, Harms P, Randers-Eichhorn L, et al. Low-cost microbioreactor for high-throughput bioprocessing. Biotechnol Bioeng, 2001, 72 (3): 346-352.
  • 4Szita N, Boccazzi P, Zhang Z, et al, Development of a multiplexed microbioreaetor system for high-throughput bioprocessing. Lab Chip, 2005, 5 (8): 819-826.
  • 5Schmidt F R. Optimization and scale up of industrial fermentation processes. Appl Microbial Bioteehnol, 2005, 68 (4): 425-435.
  • 6Taubenberger J K, Morens D M. 1918 Influenza: The mother of all pandemics [J]. Emerging Infectious Diseases, 2006, 12(1): 15-22.
  • 7H7N9禽流感最新消息:广东15人死亡,全国死亡人数超百人[N/OL].国际财经时报,(2014-02-21)[2016-05-28].http://www.ibtimes.com.cn/articles/35575/20140221/28192.htm.
  • 8Crosse M. HHS has funded flexible manufacturing activities for medical countermeasures, but it is too soon to assess their effect [J]. Gao Reports, 2014, 35(3): 53-54.
  • 9The U.S. Department of Health and Human Services. Advanced development of recombinant influenza vaccine products and man- ufacturing capabilities for pandemic preparedness [R]. Washington DC: Department of Health and Human Services, 2009.
  • 10The U.S. Department of Health and Human Services. Fiscal year 2015 work plan (mid-year update) [R/OL]. 2015[2016-05-28]. oig.hhs.gov/reports-and-publications/archives/workplan/2015/ WP-Update-2015.pdf.

共引文献11

同被引文献47

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部